Me. Leatherman et al., CENTRAL SEROTONERGIC CHANGES FOLLOWING ANTIDEPRESSANT TREATMENT - A NEUROENDOCRINE ASSESSMENT, Psychopharmacology bulletin, 29(2), 1993, pp. 149-154
We employed a neuroendocrine challenge paradigm to study the effects o
f antidepressant treatment on serotonergic systems in depressed patien
ts. We compared the maximum prolactin response to intravenous clomipra
mine (CMI) in depressed patients who responded to antidepressant treat
ment to that of nonresponders. Pretreatment baseline prolactin concent
rations and pretreatment prolactin responses to clomipramine challenge
were not different in responders compared to nonresponders. However,
following antidepressant treatment, the 6 responders demonstrated a si
gnificant change in their clomipramine challenge test results, as indi
cated by an increase in prolactin responses. In contrast, the 7 nonres
ponders did not demonstrate a change in their prolactin response to cl
omipramine challenge following treatment. These data support the hypot
hesis that serotonergic system dysfunction, as manifested by blunted p
rolactin response to clomipramine challenge, tends to normalize after
successful treatment for depression, and that abnormal serotonergic fu
nction may be a state-dependent characteristic.